BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 22275372)

  • 1. Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis.
    Niture SK; Jaiswal AK
    J Biol Chem; 2012 Mar; 287(13):9873-9886. PubMed ID: 22275372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance.
    Niture SK; Jaiswal AK
    Free Radic Biol Med; 2013 Apr; 57():119-31. PubMed ID: 23275004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis.
    Niture SK; Jaiswal AK
    Cell Death Differ; 2011 Mar; 18(3):439-51. PubMed ID: 20865015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2/p62 signaling in apoptosis resistance and its role in cadmium-induced carcinogenesis.
    Son YO; Pratheeshkumar P; Roy RV; Hitron JA; Wang L; Zhang Z; Shi X
    J Biol Chem; 2014 Oct; 289(41):28660-75. PubMed ID: 25157103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src subfamily kinases regulate nuclear export and degradation of transcription factor Nrf2 to switch off Nrf2-mediated antioxidant activation of cytoprotective gene expression.
    Niture SK; Jain AK; Shelton PM; Jaiswal AK
    J Biol Chem; 2011 Aug; 286(33):28821-28834. PubMed ID: 21690096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer.
    Khatri R; Shah P; Guha R; Rassool FV; Tomkinson AE; Brodie A; Jaiswal AK
    Mol Cancer Ther; 2015 Jul; 14(7):1728-37. PubMed ID: 25976679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant tert-butylhydroquinone ameliorates arsenic-induced intracellular damages and apoptosis through induction of Nrf2-dependent antioxidant responses as well as stabilization of anti-apoptotic factor Bcl-2 in human keratinocytes.
    Duan X; Li J; Li W; Xing X; Zhang Y; Li W; Zhao L; Sun G; Gao XH; Li B
    Free Radic Biol Med; 2016 May; 94():74-87. PubMed ID: 26878773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioncogenic and Oncogenic Properties of Nrf2 in Arsenic-induced Carcinogenesis.
    Son YO; Pratheeshkumar P; Roy RV; Hitron JA; Wang L; Divya SP; Xu M; Luo J; Chen G; Zhang Z; Shi X
    J Biol Chem; 2015 Nov; 290(45):27090-27100. PubMed ID: 26385919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of etoposide in cancer cell lines in vitro after BCL-2 and C-RAF gene silencing with antisense oligonucleotides.
    Sypniewski D; Bednarek I; Gałka S; Loch T; Błaszczyk D; Sołtysik D
    Acta Pol Pharm; 2013; 70(1):87-97. PubMed ID: 23610963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells.
    Chen HH; Chang HH; Chang JY; Tang YC; Cheng YC; Lin LM; Cheng SY; Huang CH; Sun MW; Chen CT; Kuo CC
    Free Radic Biol Med; 2017 Dec; 113():505-518. PubMed ID: 29080842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2 Expression and Apoptosis in Quercetin-treated Malignant Mesothelioma Cells.
    Lee YJ; Lee DM; Lee SH
    Mol Cells; 2015 May; 38(5):416-25. PubMed ID: 25896339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An auto-regulatory loop between stress sensors INrf2 and Nrf2 controls their cellular abundance.
    Lee OH; Jain AK; Papusha V; Jaiswal AK
    J Biol Chem; 2007 Dec; 282(50):36412-20. PubMed ID: 17925401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
    Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
    Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene PKCε controls INrf2-Nrf2 interaction in normal and cancer cells through phosphorylation of INrf2.
    Niture SK; Gnatt A; Jaiswal AK
    J Cell Sci; 2013 Dec; 126(Pt 24):5657-69. PubMed ID: 24127568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RRx-001 protects normal tissues but not tumors via Nrf2 induction and Bcl-2 inhibition.
    Oronsky B; Scribner C; Aggarwal R; Cabrales P
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2045-2050. PubMed ID: 31250159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
    Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
    PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors.
    Taylor ST; Hickman JA; Dive C
    J Natl Cancer Inst; 2000 Jan; 92(1):18-23. PubMed ID: 10620629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance.
    Niture SK; Jain AK; Jaiswal AK
    J Cell Sci; 2009 Dec; 122(Pt 24):4452-64. PubMed ID: 19920073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor Nrf2 and antioxidant response element regulate NRH:quinone oxidoreductase 2 (NQO2) gene expression and antioxidant induction.
    Wang W; Jaiswal AK
    Free Radic Biol Med; 2006 Apr; 40(7):1119-30. PubMed ID: 16545679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of activation of the antioxidant response element and stabilization of Nrf2 by 3-(3-pyridylmethylidene)-2-indolinone (PMID) confers protection against oxidative stress-induced cell death.
    Yao JW; Liu J; Kong XZ; Zhang SG; Wang XH; Yu M; Zhan YQ; Li W; Xu WX; Tang LJ; Ge CH; Wang L; Li CY; Yang XM
    Toxicol Appl Pharmacol; 2012 Mar; 259(2):227-35. PubMed ID: 22245129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.